Ispire Technology Inc. Schedules Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call

Rhea-AI Summary

Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal fourth quarter and full year 2025 earnings conference call for September 16, 2025, at 8:00 AM ET.

The call will discuss financial results for the period ended June 30, 2025. Investors can access the call through North American toll-free number (877-451-6152) or International number (+1 201-389-0879). A live webcast will be available, and a replay will be accessible until September 30, 2025, using passcode 13755309.

LOS ANGELES, Sept. 12, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00am ET on Tuesday, September 16, 2025, to discuss the Company's financial results for its fiscal fourth quarter and full year ended June 30, 2025.

To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call."

• Date: Tuesday, September 16, 2025
  
  
• Time: 8:00am ET
  
  
• Dial-In Numbers: North America 877-451-6152 or International +1 201-389-0879

This conference call will be webcast live and can be accessed by all interested parties at https://viavid.webcasts.com/starthere.jsp?ei=1730055&tp_key=20c725b587.

Please access the link at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software.

A playback will be available until 12:00 midnight Eastern Time on Tuesday, September 30, 2025. To listen, please dial 844-512-2921 or +1 412-317-6671. Use the passcode 13755309 to access the replay.

About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Twitter and YouTube.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company meeting its investment target in Malaysia as currently planned, to a lesser degree, or at all; the Company's continued compliance with applicable laws and regulations in the jurisdictions in which it operates; the approval or rejection of any PMTA submitted by the Company; whether the Company's joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the "Joint Venture") may be successful in achieving its goals regarding age-gating technology, or otherwise, as currently contemplated, with different terms, or at all; the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company's business strategies; and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2024 and any subsequent filings which Ispire makes with the SEC, including the Ispire's Quarterly Report on Form 10-Q for the period ended March 31, 2025. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

IR Contact:
KCSA Strategic Communications
Phil Carlson
212.896.1233
ispire@kcsa.com 

PR Contact:
Ellen Mellody
570.209.2947
ispire@kcsa.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ispire-technology-inc-schedules-fiscal-fourth-quarter-and-full-year-2025-earnings-conference-call-302555253.html

SOURCE Ispire Technology Inc.

FAQ

When is Ispire Technology (ISPR) reporting Q4 2025 earnings?

Ispire Technology will report its Q4 and full year 2025 earnings on Tuesday, September 16, 2025 at 8:00 AM ET.

How can I listen to Ispire Technology's (ISPR) Q4 2025 earnings call?

Investors can listen through North American toll-free number 877-451-6152, International number +1 201-389-0879, or via webcast at the company's investor relations website.

What period will Ispire Technology's (ISPR) earnings report cover?

The earnings report will cover Ispire Technology's fiscal fourth quarter and full year ended June 30, 2025.

How long will the replay of Ispire Technology's (ISPR) earnings call be available?

The earnings call replay will be available until September 30, 2025, accessible by dialing 844-512-2921 or +1 412-317-6671 with passcode 13755309.